your shopping cart is empty.
arrowrightCONTACT
Choose your country Choose your country

Worldwide:
T: +49-30-6392-7878
X: +49-30-6392-7888

USA /Canada:
T: 1.888.578.2660
X: 1.888.578.2666

E-Mail:
peptide@jpt.com

Contact

Content follows

CATALOG PRODUCT FINDER

DOTA-TOC (DOTA-[Tyr3]-octreotide)

DOTA-TOC (DOTA-[Tyr3]-octreotide)
Qty. Amount Price
1 1.984,00 €
  
add to cart
 
 
 
Delivery in 10-12 days
Excluding tax
prices do not include tax. For shipment within Germany 19% MwSt will be included at checkout and in the invoice. For shipment within EU-countries you will need to provide the valid VAT number. International customers should note that all duties, import fees, and taxes are to be paid by the customer
and
shipping fees

DOTA-TOC (DOTA-[Tyr3]-octreotide)

Product Code: SP-CHE-001

DOTA-TOC (DOTA-[Tyr3]-octreotide), precursor for radiolabelled DOTA-TOC and ligand for somatostatin receptors. Can be bound to radionuclides for development of cancer treatment and diagnosis. For research use only!
Amino acid sequence: DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr-ol (cyclic disulfide)
Amount: Please select
Purity: >95% (HPLC-MS)
Delivery Format: Freeze dried in amber type glass vials with crimp top
Application(s): Nuclear imaging, Somatostatin receptor scintigraphy (SRS)
Indication(s)/Topic(s): Cancer, Cancer therapy
Delivery Time: 10-12 days

JPT's Single Catalog Peptides
JPT Peptide Technologies has substantial, long-standing expertise in providing custom peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All of JPT's catalogue peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT's Single Catalogue Peptides
- Whole production performed in a regulated European environment according to DIN EN ISO 9001:2015 & GCLP standards; audits welcome!
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies

DOTA-TOC (DOTA-[Tyr3]-octreotide)

References:
Read References with Specialty Peptides

Testimonial
"Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle."
Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

DOTA-TOC (DOTA-[Tyr3]-octreotide)

 
Code
Product Name
 
Price
Buy
SP-CHE-002
DOTA-TATE(DOTA-[Tyr3]-Octreotate)
Precursor for radiolabelled DOTA-TATE and ligand for somatostatin receptors. For research use only!
add to cart
SP-CHE-003
DOTA-NOC (DOTA-[Nal3]-octreotide)
Precursor for radiolabelled DOTA-NOC and ligand for somatostatin receptors. For research use only!
add to cart

Description

Product Code: SP-CHE-001

DOTA-TOC (DOTA-[Tyr3]-octreotide), precursor for radiolabelled DOTA-TOC and ligand for somatostatin receptors. Can be bound to radionuclides for development of cancer treatment and diagnosis. For research use only!
Amino acid sequence: DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr-ol (cyclic disulfide)
Amount: Please select
Purity: >95% (HPLC-MS)
Delivery Format: Freeze dried in amber type glass vials with crimp top
Application(s): Nuclear imaging, Somatostatin receptor scintigraphy (SRS)
Indication(s)/Topic(s): Cancer, Cancer therapy
Delivery Time: 10-12 days

JPT's Single Catalog Peptides
JPT Peptide Technologies has substantial, long-standing expertise in providing custom peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All of JPT's catalogue peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT's Single Catalogue Peptides
- Whole production performed in a regulated European environment according to DIN EN ISO 9001:2015 & GCLP standards; audits welcome!
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies

References

References:
Read References with Specialty Peptides

Testimonial
"Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle."
Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

Properties

Related Products

SP-CHE-002
DOTA-TATE(DOTA-[Tyr3]-Octreotate)
Precursor for radiolabelled DOTA-TATE and ligand for somatostatin receptors. For research use only!
add to cart
SP-CHE-003
DOTA-NOC (DOTA-[Nal3]-octreotide)
Precursor for radiolabelled DOTA-NOC and ligand for somatostatin receptors. For research use only!
add to cart

Quality Assurance

All production is performed according to ISO 9001:2015 standards.

ISO 9001

 
Stay in touch and be the first to receive the latest news!

Contact us:

JPT Peptide Technologies GmbH
Volmerstrasse 5
12489 Berlin, Germany
Technical Support:
T: +49-30-6392-7878
X: +49-30-6392-7888
e-mail: peptide@jpt.com
USA & Canada:
T: 1.888.JPT.COM0 (1.888.578.2660)
X: 1.888.JPT.COM6 (1.888.578.2666)
e-mail: peptide@jpt.com